INNOCARE PHARMA LIMITED revenue breakdown overview

INNOCARE PHARMA LIMITED revenue for the last year amounted to 738.54 M CNY, the most of which — 738.54 M CNY — came from its highest performing source at the moment, Biopharmaceutical Research and Development, Manufacturing, Commercialization and Services, the year earlier bringing 625.40 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought INNOCARE PHARMA LIMITED 673.13 M CNY, and the year before that — 568.04 M CNY.